Castle Biosciences stock falls following Medicare coverage denial
Investing.com — Shares of Castle Biosciences (NASDAQ:CSTL) tumbled 9% after Novitas, a regional Medicare contractor, finalized its decision not to cover one
Investing.com — Shares of Castle Biosciences (NASDAQ:CSTL) tumbled 9% after Novitas, a regional Medicare contractor, finalized its decision not to cover one
By Nate Raymond (NS:RYMD) (Reuters) – A former partner at McKinsey & Co pleaded guilty on Friday to obstructing justice by
Investing.com — Though financial technology sector enters 2025 with a generally positive outlook, supported by macroeconomic support and trends in payment digitization, analysts
Investing.com — Shares of Wyndham climbed 2.5% after Wells Fargo (NYSE:WFC) Securities upgraded the hotel operator to overweight from equal-weight,
(Reuters) – The U.S. has sued to block a proposed merger between American Express (NYSE:AXP) Global Business Travel Group and
By Nate Raymond (NS:RYMD) (Reuters) -A U.S. appeals court on Friday revived a lawsuit by a conservative group opposed to diversity
By Katie Paul (Reuters) – Meta Platforms (NASDAQ:META) is ending its diversity, equity, and inclusion (DEI) programs, including those for hiring, training and
Investing.com — WingStop has been added to the Wedbush Best Ideas List, with the firm forecasting strong growth potential for the company in
(Reuters) – The European Commission on Friday said it had approved under conditions the takeover by chip design software maker Synopsys (NASDAQ:SNPS)
By Nora Eckert and Kalea Hall DETROIT (Reuters) – Automaker Stellantis (NYSE:STLA) achieved its goal of cutting U.S. inventories by over 100,000 vehicles